Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Fibronostics logo — An In vitro diagnostics platform for metabolic conditions de...

Fibronostics

An In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.

Founded 2015 United States Orlando, United States 23 employees Health Care

General Information

Company Name Fibronostics
Founded Year 2015
Location United States Orlando, United States +2
Employees 23
Industries Health Care
Social

Get notified when Fibronostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Fibronostics

Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibronostics'​ LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool. Fibronostics'​ HealthFACTR tool employes technology to predict risk, providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease. HealthFACTR enables action-oriented recommendations which allow healthcare professions to determine patients'​ risk levels and drive better patient care.

Taxonomy: In vitro diagnostics, Metabolic conditions, Artificial intelligence, Diagnostic testing, Liver disease, NAFLD, NASH, Chronic diseases, Coronary heart disease, Stroke, Diabetes, Obstructive sleep apnea, Non-invasive diagnostics, Machine learning

No funding data available for Fibronostics yet.

Get notified when Fibronostics raises funding

Fibronostics Alternatives & Competitors

Fibronostics vs
GENinCode Predictive Genetics
GENinCode Predictive Genetics United Kingdom

Clinical Genetics and Precision Medicine. Safeguarding your future health.

Post Ipo Equity
47 employees
Biotechnology, Health Care
Fibronostics vs
Prolocor
Prolocor United States

Advancing patient care by empowering physicians with effective precision diagnostics for cardiovascu...

Convertible Note
8 employees
Biotechnology, Health Care
Fibronostics vs
HeartSciences (NASDAQ:HSCS)
HeartSciences (NASDAQ:HSCS) United States

Millions of ECGs are performed every week with technology that hasn't changed in 50 years. We intend...

Debt Financing
20 employees
AI, Health Care

FAQ About Fibronostics

An In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.
Fibronostics was founded in 2015.
Fibronostics is headquartered in Orlando, United States.
Fibronostics operates in the following industries: Health Care.
Fibronostics has approximately 23 employees.
Top alternatives and competitors to Fibronostics include GENinCode Predictive Genetics , Prolocor, HeartSciences (NASDAQ:HSCS), Ashchi Heart & Vascular Center, PA, Radisens Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Fibronostics and GENinCode Predictive Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Fibronostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy